Wednesday, 1 July 2026
PERSPECTA
News from every angle
All
Stream
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny
4 Mar, 07:30 — 4 Mar, 07:30
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
119d ago
Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny
Read full article →
Something wrong with this story? Report an issue
Related Stories
Oldest Plague Outbreak Discovered in Siberia, Dating Back 5,500 Years
just now
Extreme Training: What Heat Training Does to the Body
just now
Cocaine Addiction on the Rise in Iceland
33m ago
West Nile Virus Detected in Nashville Mosquitoes
34m ago
Wednesday, 1 July 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
